Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives

Figure 4

Particle size distribution patterns of ASC-DP/surfactant (1 : 1 molar ratio) suspensions. The surfactants included (a) SDS, (b) CTAB, (c) Brij78, and (d) DSPE-PEG.

(a)

(b)

(c)

(d)